Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer discovery

Showing results (401-410 of 4,677) with videos related to

Pageof 468
Sort By:
Cancer Discovery|April 15, 2021
Mechanisms of KRAS Inhibitor Resistance Revealed
Cancer Discovery|March 29, 2013
Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenanceAdrienne L Watson, Eric P Rahrmann, Branden S Moriarity, et al.
Cancer Discovery|March 23, 2013
Multifunctional T-cell analyses to study response and progression in adoptive cell transfer immunotherapyChao Ma, Ann F Cheung, Thinle Chodon, et al.
Cancer Discovery|May 16, 2012
Drug discovery gets an academic push
Cancer Discovery|May 16, 2012
What's cost-effective in cancer care?
Cancer Discovery|May 16, 2012
Making molecular diagnostics ready for prime timeErika Jonietz
Cancer Discovery|May 16, 2012
Q&A: William Sellers on success in small molecules. Interview by Eric BenderWilliam Sellers
Cancer Discovery|May 16, 2012
Anti-MET targeted therapy has come of age: the first durable complete response with MetMAb in metastatic gastric cancerYan Feng, Patrick C Ma
Cancer Discovery|May 16, 2012
Genomic investigation of dedifferentiated liposarcoma suggests a role for therapeutic targeting of the tumor epigenomePaul S Meltzer, Lee J Helman
Cancer Discovery|May 16, 2012
Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancerRosalyn A Juergens, John Wrangle, Frank P Vendetti, et al.
Pageof 468

Showing results (401-410 of 4,677) with videos related to

Sort By:
Pageof 468
Cancer Discovery|April 15, 2021
Mechanisms of KRAS Inhibitor Resistance Revealed
Cancer Discovery|March 29, 2013
Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenanceAdrienne L Watson, Eric P Rahrmann, Branden S Moriarity, et al.
Cancer Discovery|March 23, 2013
Multifunctional T-cell analyses to study response and progression in adoptive cell transfer immunotherapyChao Ma, Ann F Cheung, Thinle Chodon, et al.
Cancer Discovery|May 16, 2012
Drug discovery gets an academic push
Cancer Discovery|May 16, 2012
What's cost-effective in cancer care?
Cancer Discovery|May 16, 2012
Making molecular diagnostics ready for prime timeErika Jonietz
Cancer Discovery|May 16, 2012
Q&A: William Sellers on success in small molecules. Interview by Eric BenderWilliam Sellers
Cancer Discovery|May 16, 2012
Anti-MET targeted therapy has come of age: the first durable complete response with MetMAb in metastatic gastric cancerYan Feng, Patrick C Ma
Cancer Discovery|May 16, 2012
Genomic investigation of dedifferentiated liposarcoma suggests a role for therapeutic targeting of the tumor epigenomePaul S Meltzer, Lee J Helman
Cancer Discovery|May 16, 2012
Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancerRosalyn A Juergens, John Wrangle, Frank P Vendetti, et al.
Pageof 468